Show simple item record

Congenital-infantile fibrosarcoma of the foot: avoidance of amputation

dc.contributor.authorNason, GJ
dc.contributor.authorBaker, JF
dc.contributor.authorSeoighe, D
dc.contributor.authorIrvine, AD
dc.contributor.authorMc Dermott, M
dc.contributor.authorOrr, D
dc.contributor.authorCapra, M
dc.contributor.authorKelly, PM
dc.date.accessioned2014-05-16T11:47:28Z
dc.date.available2014-05-16T11:47:28Z
dc.date.issued2014-05
dc.identifier.citationNason GF et al.en_GB
dc.identifier.urihttp://hdl.handle.net/10147/317074
dc.description.abstractCongenital-infantile fibrosarcoma is a rare entity with a five year survival rate of over 90%. Surgery is still the most common treatment modality with amputation often necessary. There have been reports supporting the use of neoadjuvant chemotherapy to debulk the tumour in an effort to facilitate limb sparing surgery. We report a case of a newborn who presented with a life threatening haemorrhage from a fibrosarcoma of the foot, successfully treated with Vincristine, Actinomycin and Cyclophosphamide (VAC) chemotherapy alone.
dc.language.isoenen
dc.publisherIrish Medical Journalen_GB
dc.subjectNEONATEen_GB
dc.subjectCANCERen_GB
dc.subjectCHEMOTHERAPYen_GB
dc.subject.otherAMPUTATIONen_GB
dc.titleCongenital-infantile fibrosarcoma of the foot: avoidance of amputationen_GB
dc.typeArticleen
dc.identifier.journalIrish Medical Journalen_GB
dc.description.fundingNo fundingen
dc.description.provinceLeinsteren
dc.description.peer-reviewpeer-reviewen
refterms.dateFOA2018-08-30T10:46:06Z
html.description.abstractCongenital-infantile fibrosarcoma is a rare entity with a five year survival rate of over 90%. Surgery is still the most common treatment modality with amputation often necessary. There have been reports supporting the use of neoadjuvant chemotherapy to debulk the tumour in an effort to facilitate limb sparing surgery. We report a case of a newborn who presented with a life threatening haemorrhage from a fibrosarcoma of the foot, successfully treated with Vincristine, Actinomycin and Cyclophosphamide (VAC) chemotherapy alone.


Files in this item

Thumbnail
Name:
Article7580.pdf
Size:
10.70Kb
Format:
PDF
Download

This item appears in the following Collection(s)

Show simple item record